NDC

PIS with BGN Adds Two Giant Gas Tankers, Supporting Energy Resilience and Global Market Expansion for Indonesia

Retrieved on: 
Thursday, January 11, 2024

Named the VLGC Pertamina Gas Tulip and the VLGC Pertamina Gas Bergenia, they are among the world's largest gas tankers, environmentally friendly and using the latest technology.

Key Points: 
  • Named the VLGC Pertamina Gas Tulip and the VLGC Pertamina Gas Bergenia, they are among the world's largest gas tankers, environmentally friendly and using the latest technology.
  • "The presence of these two VLGC ships will undoubtedly enhance the capability of the Pertamina Group in securing energy supplies to support national energy resilience.
  • We are pleased to help strengthen the energy security of Indonesia at the same time as supporting BGN's global energy and commodities trading platform with these maritime assets."
  • The vessels' sustainability advantages that contribute to the global energy transition include having dual-fuel tanks, enabling the optimization of low sulfur fuel and gas.

Maktar Launches Revolutionary USB 3 MFi-Certified Piconizer 4s at CES 2024

Retrieved on: 
Wednesday, January 10, 2024

During a session jointly hosted by the Department of Industrial Technology of MOEA and the Taiwan-US start-up ecosystem in San Francisco, Maktar, along with 34 start-ups from the 2024 CES TTA (Taiwan Tech Arena) Pavilion, took part in Taiwan Demo Day.

Key Points: 
  • During a session jointly hosted by the Department of Industrial Technology of MOEA and the Taiwan-US start-up ecosystem in San Francisco, Maktar, along with 34 start-ups from the 2024 CES TTA (Taiwan Tech Arena) Pavilion, took part in Taiwan Demo Day.
  • Maktar stood out by winning the "Best Pitch" award with their 3-minute presentation.
  • At CES, Maktar introduced the Piconizer 4s, the first USB 3 MFi Apple-certified storage device for iPhone 15 Pro/Pro Max.
  • The event saw the participation of over 4,000 tech companies from more than 150 countries and regions worldwide.

Sabre and IAG expand partnership with multi-year distribution agreement including NDC content

Retrieved on: 
Tuesday, January 9, 2024

The agreement will allow Sabre-connected travel buyers and agencies to sell traditional EDIFACT content as well as having competitive access to NDC offers from British Airways, Iberia, Aer Lingus and Vueling – including Additional Price Points and ancillaries – through the Sabre travel marketplace globally.

Key Points: 
  • The agreement will allow Sabre-connected travel buyers and agencies to sell traditional EDIFACT content as well as having competitive access to NDC offers from British Airways, Iberia, Aer Lingus and Vueling – including Additional Price Points and ancillaries – through the Sabre travel marketplace globally.
  • Sabre and IAG's airlines are working closely together and will communicate as NDC content is rolled out to Sabre-connected travel agencies on a carrier-by-carrier basis.
  • The agreement between Sabre and IAG underscores the industry's shift towards modern travel retailing, where airlines can differentiate their offerings and provide more personalized experiences to travelers.
  • This agreement is another milestone in the IAG strategy to embrace digital retailing practices and offer more opportunities for customers to access NDC content.

Travelport Completes New Equity Financing

Retrieved on: 
Wednesday, January 3, 2024

LANGLEY, UK, Jan. 3, 2024 /PRNewswire/ -- Travelport (the "Company"), a global technology company that powers travel bookings for hundreds of thousands of travel suppliers worldwide, today announced that it has completed its previously announced financing transaction with a group of its existing equity holders and lenders who have invested $570 million in new equity into the Company.

Key Points: 
  • LANGLEY, UK, Jan. 3, 2024 /PRNewswire/ -- Travelport (the "Company"), a global technology company that powers travel bookings for hundreds of thousands of travel suppliers worldwide, today announced that it has completed its previously announced financing transaction with a group of its existing equity holders and lenders who have invested $570 million in new equity into the Company.
  • It also positions Travelport to continue investing in its technology platforms and innovating new, exceptional ways for the travel industry to serve its customers.
  • "The completion of Travelport's previously announced financing transaction represents the strong belief our investors have in our competitive position and potential for long-term growth," said Greg Webb, Chief Executive Officer of Travelport.
  • "Our new financing allows us to continue to innovate, enhance and deliver the best-in-class technology our partners have come to expect from us.

Coherus Announces U.S. Launch of LOQTORZI™

Retrieved on: 
Tuesday, January 2, 2024

REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that LOQTORZI™ (toripalimab-tpzi) is now available through select specialty distributors in the United States. LOQTORZI is indicated in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC), and as monotherapy for the treatment of adults with recurrent, unresectable, or metastatic NPC with disease progression on or after platinum-containing chemotherapy. LOQTORZI is a next-generation, programmed death receptor-1 (PD-1) monoclonal antibody that blocks PD-1 ligands PD-L1 and PD-L2 with high potency at a unique site on the PD-1 receptor, enabling the immune system to activate and kill the tumor.

Key Points: 
  • In December, the NCCN committee classified LOQTORZI as a preferred category 1 treatment option in combination with gemcitabine and cisplatin.
  • LOQTORZI has demonstrated impressive clinical benefits, including PFS and OS, offering R/M NPC patients new hope for extended survival,” said Paul Reider, Chief Commercial Officer of Coherus.
  • Contact Coherus BioSciences Customer Services at 1-844-562-6004 for more information.
  • Coherus expects a product-specific, permanent J-code to be assigned to LOQTORZI in mid-2024.

Natco Pharma Limited Completes Transition of DASH Pharmaceuticals into Natco Pharma USA, Furthering Strategic Presence in the United States

Retrieved on: 
Tuesday, January 2, 2024

Natco Pharma Limited, a research and development (R&D)-focused pharmaceutical company based in India, today announced that DASH Pharmaceuticals, a company that markets, sells, and distributes generic pharmaceutical products, has officially transitioned to Natco Pharma USA, the U.S. subsidiary of Natco Pharma.

Key Points: 
  • Natco Pharma Limited, a research and development (R&D)-focused pharmaceutical company based in India, today announced that DASH Pharmaceuticals, a company that markets, sells, and distributes generic pharmaceutical products, has officially transitioned to Natco Pharma USA, the U.S. subsidiary of Natco Pharma.
  • As of January 2, all products marketed by the company will transition to the Natco Pharma USA label, with no changes to the current NDC Numbers.
  • Julie Trendowicz and Nick DiMaio, the former Executive Vice President and President of DASH, respectively, will assume the same roles under Natco Pharma USA.
  • “By acquiring DASH, Natco Pharma has gained a strategic presence in the United States, connecting us directly with our valued customers in this crucial market,” said Subba Rao Mente, Chief Executive Officer of Natco Pharma USA.

Pertamina Reaffirms its Commitment to Net Zero Emissions by 2060

Retrieved on: 
Monday, December 4, 2023

Therefore, Pertamina has developed initiatives for managing sustainability while maintaining energy security and strengthening energy equality.

Key Points: 
  • Therefore, Pertamina has developed initiatives for managing sustainability while maintaining energy security and strengthening energy equality.
  • Pertamina is carrying out three initiatives towards energy efficiency, as it is essential and more manageable for reducing emissions.
  • From these three operations through the end of last year, Pertamina successfully reduced 31 percent of emissions in its internal operations.
  • As a leading company in the energy transition sector, Pertamina is committed to supporting the 2060 Net Zero Emission target by continuing to encourage programs that directly impact the achievement of Sustainable Development Goals (SDGs).

ARC and Air Canada Implement NDC with ARC Direct Connect

Retrieved on: 
Wednesday, December 20, 2023

ARLINGTON, VA., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Airlines Reporting Corp. (ARC) is pleased to announce the completion of Air Canada’s New Distribution Capability (NDC) integration with the ARC Direct Connect program.

Key Points: 
  • ARLINGTON, VA., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Airlines Reporting Corp. (ARC) is pleased to announce the completion of Air Canada’s New Distribution Capability (NDC) integration with the ARC Direct Connect program.
  • This partnership enables Air Canada to offer richer content and detailed information through its booking platforms for corporate travel buyers and travel agencies while providing a consistent settlement experience through ARC’s trusted platform.
  • This offers the full suite of capabilities and payment options to service our mutual customers in the channel of their choice.”
    “We’re thrilled to welcome Air Canada to the ARC Direct Connect program and help them transform how they communicate with travel agencies and travel managers,” said Paige Blunt, senior manager of Direct Connect and ONE Order at ARC.
  • “ARC Direct Connect will help differentiate Air Canada’s products and create a more consistent shopping experience across channels with access to content previously only available in the airline’s direct channel.”
    Introduced in 2018, ARC Direct Connect gives airlines the flexibility to implement distribution strategies that best suit their needs and manage travel agency partnerships.

Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination

Retrieved on: 
Friday, November 17, 2023

Bayer is voluntarily recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles to the consumer/user level.

Key Points: 
  • Bayer is voluntarily recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles to the consumer/user level.
  • The product is being recalled due to microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing.
  • To date, Bayer has not received any adverse events related to this recall.
  • Bayer has engaged Qualanex to manage the recall of the product down to the consumer level.

Paris Agreement Article 6 Implementation Partnership (A6IP) Center is now fully operational and ready to support capacity building implementation of Article 6

Retrieved on: 
Friday, November 10, 2023

The Institute for Global Environmental Strategies (IGES) is proud to announce the start of operations for the “Paris Agreement Article 6 Implementation Partnership (A6IP) Center”.

Key Points: 
  • The Institute for Global Environmental Strategies (IGES) is proud to announce the start of operations for the “Paris Agreement Article 6 Implementation Partnership (A6IP) Center”.
  • The A6IP Center tailors every Support Package to align with the unique needs, priorities and readiness status of each partner country.
  • The A6IP Center provides a comprehensive Support Package and the flexibility to choose individual support options, ensuring a customised and effective approach to support.
  • Support Package optional components are as follows:
    Development of Article 6 Strategy: Paris Agreement and Article 6; Enhancing ambition through Article 6; and participation requirement for Article 6.